JSE Daily Intelligence

JSE closes 0.8% lower as Sasol's 9.9% surge cushions risk-off

A Brent spike to a 14-month high and a weaker rand split the market: commodity earners rallied while domestic-facing financials and retailers bore the cost pressure.

A risk-off session driven by a VIX spike and weaker US markets left the JSE nursing broad losses, but a Brent-fuelled 9.9% surge in Sasol kept the damage from being worse.

How the day unfolded

Overnight weakness in US equities and a jump in the VIX set a negative tone from the open, with the All Share down sharply by midday and breadth at just 24 advancers against 112 decliners. A Brent crude surge to a 14-month high of $101.12 and a weaker rand at R16.04 to the dollar provided support for energy and commodity names, helping the market recover into the afternoon. The All Share closed down 0.80% and the Top 40 down 0.86%.

Telecommunications (+1.58%), chemicals (+7.78%) and health care (+0.59%) led the session, while consumer discretionary (-1.94%), banks (-1.89%) and life insurance (-1.84%) were the heaviest drags. The rand's 0.33% depreciation compounded cost pressures for domestic-facing SA Inc. names, even as it flattered USD earners.

By the numbers

Index Close Change
All Share 116,520 -0.80%
Top 40 109,091 -0.86%
Mid Cap 107,195 +0.22%
Small Cap 105,831 -0.20%
Resource 20 138,178 -0.18%
Industrial 25 120,392 -0.68%
Financial 15 25,939 -1.76%
FINANCIALS AND INDUSTRIALS 13,127 -1.12%
SA LISTED PROPERTY INDEX 483.4 -0.56%
Sector Close Change
FTSE/JSE Chemicals 12,704 +7.78%
FTSE/JSE Telecommunications 9,089 +1.58%
FTSE/JSE Health Care 5,348 +0.59%
FTSE/JSE Industrial Transportation 478.73 -0.20%
FTSE/JSE Banks 16,548 -1.89%
FTSE/JSE Consumer Discretionary 39,377 -1.94%
FTSE/JSE Beverages 242.79 -3.64%
FTSE/JSE Personal Goods 3,548 -4.11%

Breadth: 48 advances, 107 declines, 12 unchanged.

Macro Level Change
Rand/USD 16.0352 +0.33%
EUR/ZAR 18.6403 +0.31%
GBP/ZAR 21.719 +0.32%
Gold 4,389.65 +0.82%
Platinum 1,910.35 +3.08%
Palladium 1,369 -0.01%
Brent 101.12 +3.27%
Iron Ore 100.02 +0.45%
S&P 500 7,629.44 -0.57%
Nasdaq 100 26,229.16 -0.73%
FTSE 100 10,660.01 -1.40%
VIX 16.58 +5.47%
Bitcoin 78,351.83 -0.11%

LAB Hollard seeks liquidation on ~R20m judgment; court reserves ruling

Hollard has filed a liquidation application against Labat Africa based on a judgment of roughly R20m granted in January 2024, stemming from a 2020 deed of suretyship. Labat's rescission application to overturn that judgment remains pending and unopposed.

Both the liquidation and postponement applications were heard on 1 September 2026, and judgment has been reserved. The filing does not quantify either Hollard's claimed figure or the amount Labat contends is properly due, so the disputed liability cannot be sized.

Since February 2026 Labat has entered settlement and repayment arrangements with various creditors who had instituted or threatened proceedings, indicating active litigious exposure across several fronts. The court's ruling on the liquidation and postponement applications is the next disclosure that will settle the direction of this risk.

SSU Southern Sun guides H1 earnings up at least 20% on 12% revenue growth

Southern Sun expects EPS, HEPS and AHEPS for the six months to 30 September 2026 to be at least 20% higher than the prior period, a floor of roughly 4.9c above H1 FY26's 24.5c/24.8c/24.9c. Group revenue rose 12% for the five months to August, with occupancy up from 57.8% to 60.2% and average room rates up 9.5%.

The offshore segment grew revenue 54%, supported by the Paradise Sun relaunch and rising volumes in Mozambique and Tanzania. Since 1 April 2026 the group has repurchased R174m of shares at an average R9.98 and paid a R393m final FY26 dividend.

The guidance is a fresh earnings floor after a flat share run, but above-inflation cost pressures across IT upgrades, utilities, property rates and channel costs threaten to compress Ebitdar. The October trading statement and 18 November interim results are the next tests of whether the 20% floor is cash-backed.

HYP Hyprop hits upper end of DIPS guidance at 423c but FY27 growth slows to 7-9%

Hyprop reported FY2026 distributable income per share of 423.0c, up 11.7% and at the upper end of its 10–12% guidance, with net operating income up 16.5% to R1.861bn. The group LTV improved to 28.5% from 33.6%, SA retail reversions turned positive at 8.7%, and average borrowing costs fell to 8.5% in ZAR and 3.9% in EUR.

The key number is the FY2027 outlook: DIPS growth of 7–9%, implying roughly 452.6c–461.1c, a clear step down from the current pace. The guidance assumes no major tenant failures, no further economic deterioration, and interest rates at current levels.

GRT Growthpoint meets DIPS and DPS guidance but HEPS falls 24.9% and reversions worsen

Growthpoint delivered DIPS up 4.3% to 152.6c and DPS up 7.4% to 133.5c, both within the ranges reaffirmed in June. The V&A Waterfront contributed distributable income of R964.7m, up 19%, and the SA REIT LTV improved to 38.7% with ICR at 2.63x.

Beneath the distribution story, basic HEPS fell 24.9% to 119.4c and overall lease reversions deteriorated to -2.3% from -0.9%, with office reversions at -6.3%. The next investor update will test whether the HEPS decline reverses and offshore distributions stabilise.

ITE Italtile drops 7.7% after intragroup share transfer and director retention awards

Italtile's Retention Scheme Trust bought 8.4 million shares from Italtile Ceramics at R9.29, a R78m intragroup transfer that lifted treasury shares to 152.5 million. Directors Brandon Wood and Lamar Booysen were awarded 5.5 million units at zero exercise price with five-year performance vesting, a deemed value of R51.1m combined.

The share fell 7.73% on the day, with the growing treasury share overhang and unspecified performance criteria creating dilution risk. No cash changed hands and there was no open-market trade, but the market's reaction signalled displeasure with the transaction.

NVS Novus lifts Mustek stake to 57.58% but R15.41 offer uplift still awaits TSC confirmation

Novus increased its direct Mustek stake to 57.58%, with concert parties at approximately 77.87%, buying small parcels on market at R15.15 per share. The highest price paid by Novus and its concert parties is R15.25, below the R15.41 it is committed to pay under the mandatory offer.

The R15.41 per share offer uplift remains conditional on the Takeover Special Committee confirming the Settlement Agreement as an order, which has not occurred as at this announcement. The Mustek takeover has been under TRP investigation since August 2025, and no timetable for the TSC confirmation is provided.

UPL Universal Partners narrows loss to GBP1.34m but portfolio valuations stay flat

Universal Partners reported a net loss of GBP1.34m for FY2026, down from GBP8.42m, with NAV per share slipping to GBP1.158 from GBP1.176. The three core investee valuations were all held flat, including PD despite its disclosed UK underperformance, and no dividend was declared. The improvement was driven by fair value gains and a performance-fee reversal rather than portfolio performance, leaving little evidence of genuine progress.

Movers explained

Sasol's advance was macro-driven, with Brent's 3.27% jump and the weaker rand amplifying USD earnings. Thungela gained 4.86% on the same rand-hedge logic, while Afrimat rose 4.52% in sympathy with Basic Materials. Montauk Renewables (+6.19%) and Frontier Transport (+4.17%) had no disclosed catalyst. On the downside, Italtile's slide reflected the intragroup share transfer and retention awards, Libstar fell 6.39% after a SENS release without a published headline, and Cashbuild lost 4.19% in line with Consumer Cyclical weakness. Insimbi's 7.69% drop came in a thinly traded stock with no disclosed catalyst, and ASP Isotopes fell 4.69% after a SENS release.

What we are watching

The next catalysts are the court's ruling on Labat's liquidation and rescission applications, the TSC's confirmation of Novus's Settlement Agreement, and Southern Sun's October trading statement ahead of 18 November results. Hyprop's next trading update will show whether FY2027 DIPS growth is tracking the 7–9% guide, while Growthpoint's next investor update tests the HEPS decline and offshore distributions.

Frequently asked

Why did Sasol jump 9.9% on Wednesday?

Brent crude rose 3.27% to $101.12, a 14-month high, and the rand weakened 0.33% to R16.04, amplifying Sasol's USD-denominated earnings.

How did the JSE close on Wednesday?

The All Share closed 0.80% lower at 116,520 and the Top 40 fell 0.86% to 109,091, with 48 advancers against 107 decliners.

What did Southern Sun's trading statement say?

Southern Sun expects H1 EPS, HEPS and AHEPS to be at least 20% higher than the prior period, with revenue up 12% for the five months to August.

Why did Italtile fall 7.73%?

The Retention Scheme Trust bought 8.4 million shares from Italtile Ceramics at R9.29 and directors were awarded 5.5 million units, lifting treasury shares and creating dilution concerns.

What is the Labat Africa liquidation update?

Hollard filed a liquidation application based on a roughly R20m January 2024 judgment; Labat's rescission application is pending and judgment was reserved after a 1 September hearing.

What is Hyprop's FY2027 outlook?

Hyprop guides FY2027 DIPS growth of 7–9%, implying roughly 452.6c–461.1c, a step down from FY2026's 11.7% growth to 423.0c.